Relatively strong set of H1 FY21 figures, not surprisingly driven by the strong US consumption and the Chinese recovery. No FY21 EBIT guidance given, while the group expects organic sales growth for the year.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Relatively strong set of H1 FY21 figures, not surprisingly driven by the strong US consumption and the Chinese recovery. No FY21 EBIT guidance given, while the group expects organic sales growth for the year.
